Joseph A DiGiuseppe
Affiliation: Hartford Hospital
- Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapyJoseph A DiGiuseppe
Department of Pathology and Laboratory Medicine, Special Hematology Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102 5037, USA
Clin Lab Med 27:533-49, vi. 2007..Flow cytometric detection of minimal residual disease is among the strongest prognostic factors in patients who have ALL and may provide an opportunity for more precise risk-adapted therapies...
- Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detectionJoseph A DiGiuseppe
Department of Pathology and Laboratory Medicine, Hartford Hospital, Connecticut 06102 5037, USA
Cytometry B Clin Cytom 76:150-5. 2009..However, whether CD49f might be a useful reagent in the immunophenotypic detection of MRD in pB-ALL has not been evaluated...
- Improved compensation of the fluorochrome AmCyan using cellular controlsJoseph A DiGiuseppe
Special Hematology Laboratory, Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, Connecticut 06102 5037, USA
Cytometry B Clin Cytom 80:191-4. 2011....
- Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemiaMatthew T Hurford
Department of Pathology and Laboratory Medicine, Temple University Medical Center, Philadelphia, PA 19140, USA
Am J Clin Pathol 129:700-5. 2008..The nuclear pattern of immunofluorescence using antibodies to TdT is an effective method for distinguishing hematogones from leukemic blasts...
- Flow cytometric immunophenotyping of plasmacytic neoplasmsJoseph A DiGiuseppe
Am J Clin Pathol 127:172-4. 2007